Zhu Kai-Yi, Hei Ming-Yan
Neonatal Center, Beijing Children's Hospital, Capital Medical University/National Center for Child Health, Beijing 100045, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2021 May;23(5):536-541. doi: 10.7499/j.issn.1008-8830.2102045.
Neonatal hypoxic-ischemic brain damage (HIBD) remains an important cause of neonatal death and disability in infants and young children, but it has a complex mechanism and lacks specific treatment methods. As a new type of programmed cell death, ferroptosis has gradually attracted more and more attention as a new therapeutic target. This article reviews the research advances in abnormal iron metabolism, glutamate antiporter dysfunction, and abnormal lipid peroxide regulation which are closely associated with ferroptosis and HIBD.
新生儿缺氧缺血性脑损伤(HIBD)仍然是婴幼儿死亡和残疾的重要原因,但它机制复杂且缺乏特异性治疗方法。作为一种新型的程序性细胞死亡,铁死亡作为一种新的治疗靶点逐渐受到越来越多的关注。本文综述了与铁死亡和HIBD密切相关的铁代谢异常、谷氨酸反向转运体功能障碍以及脂质过氧化物调节异常的研究进展。